 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - CRISPR Therapeutics AG (CRSP)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-19 Sale | 2019-11-21 7:53 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 42,000 | $67.41 | $2,831,388 | 2,238,979 (Indirect Direct) | View |
| 2019-11-19 Sale | 2019-11-21 4:09 pm | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 33,618 | $70 | $2,353,260 | 236,382 (Direct) | View |
| 2019-11-19 Sale | 2019-11-21 4:07 pm | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $62 | $465,000 | 63,833 (Direct) | View |
| 2019-11-12 Sale | 2019-11-13 4:30 pm | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $55 | $412,500 | 71,333 (Direct) | View |
| 2019-10-30 Sale | 2019-11-01 6:35 pm | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $52 | $390,000 | 78,833 (Direct) | View |
| 2019-10-30 Sale | 2019-11-01 6:34 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 21,000 | $51.89 | $1,089,675 | 2,238,979 (Indirect Direct) | View |
| 2019-07-10 Sale | 2019-07-12 4:13 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $50.02 | $1,000,353 | 72,087 (Direct) | View |
| 2019-07-10 Sale | 2019-07-12 4:10 pm | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 50,000 | $50 | $2,500,065 | 848,007 (Direct) | View |
| 2019-06-17 Sale | 2019-06-19 4:15 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $46 | $920,000 | 203,058 (Direct) | View |
| 2019-06-10 Sale | 2019-06-12 4:16 pm | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 50,000 | $45 | $2,250,000 | 898,007 (Direct) | View |
| 2019-04-29 Sale | 2019-05-01 4:05 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $42.03 | $840,600 | 223,058 (Direct) | View |
| 2019-03-01 Sale | 2019-03-05 5:59 pm | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 85,220 | $40.4 | $3,443,037 | 1,024,534 (Direct) | View |
| 2019-02-25 Sale | 2019-02-27 4:10 pm | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 14,780 | $40 | $591,233 | 1,033,227 (Direct) | View |
| 2018-12-18 Sale(A) | 2019-01-18 4:32 pm | CRISPR Therapeutics AG | CRSP | EMSTER KURT VON Director | 62,925 | $29.7 | $1,869,168 | 1,171,268 (Indirect) | View |
| 2019-01-08 Sale | 2019-01-10 4:09 pm | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 100,000 | $35.02 | $3,502,385 | 1,130,697 (Direct) | View |
| 2018-12-26 Purchase | 2018-12-28 4:34 pm | CRISPR Therapeutics AG | CRSP | Vertex Pharmaceuticals (Europe) Ltd VERTEX PHARMACEUTICALS INC 10% Owner | 40,198 | $24.93 | $1,002,194 | 5,380,940 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-12-03 Option Award | 2019-12-05 4:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-12-03 Option Award | 2019-12-05 4:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-12-03 Option Award | 2019-12-05 4:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 120,000 | $0 | 120,000 (Direct) | View |
| 2019-12-03 Option Award | 2019-12-05 4:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-12-03 Option Award | 2019-12-05 4:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-12-01 Tax Withholding | 2019-12-02 5:12 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 741 | $71.65 | 164,320 (Direct) | View |
| 2019-11-19 Exercise | 2019-11-21 4:09 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 33,618 | $14.43 | 236,382 (Direct) | View |
| 2019-11-19 Exercise | 2019-11-21 4:09 pm | N/A 2024-01-15 | CRISPR Therapeutics AG | CRSP | Novak Rodger President | 33,618 | $14.43 | 236,382 (Direct) | View |
| 2019-11-19 Exercise | 2019-11-21 4:07 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $5.59 | 63,833 (Direct) | View |
| 2019-11-19 Exercise | 2019-11-21 4:07 pm | N/A 2025-11-04 | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $5.59 | 63,833 (Direct) | View |
| 2019-11-12 Exercise | 2019-11-13 4:30 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $5.59 | 71,333 (Direct) | View |
| 2019-11-12 Exercise | 2019-11-13 4:30 pm | N/A 2025-11-04 | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $5.59 | 71,333 (Direct) | View |
| 2019-10-30 Exercise | 2019-11-01 6:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $5.59 | 78,833 (Direct) | View |
| 2019-10-30 Exercise | 2019-11-01 6:35 pm | N/A 2025-11-04 | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $5.59 | 78,833 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 4:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 10,000 | $0 | 10,000 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 4:32 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 10,000 | $0 | 30,000 (Direct) | View |
| 2019-09-01 Tax Withholding | 2019-09-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 740 | $46.21 | 165,061 (Direct) | View |
| 2019-08-01 Exercise | 2019-08-05 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 37,500 | $0 | 60,369 (Direct) | View |
| 2019-08-01 Tax Withholding | 2019-08-05 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 14,534 | $52.56 | 60,369 (Direct) | View |
| 2019-08-01 Exercise | 2019-08-05 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W VP | 37,500 | $0 | 60,369 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 11,579 | $5.86 | 72,087 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 8,421 | $5.86 | 72,087 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 11,579 | $5.86 | 72,087 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 8,421 | $5.86 | 72,087 (Direct) | View |
| 2019-06-17 Exercise | 2019-06-19 4:15 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $1.81 | 203,058 (Direct) | View |
| 2019-06-17 Exercise | 2019-06-19 4:15 pm | N/A 2025-09-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $1.81 | 203,058 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-13 8:49 pm | N/A 2029-06-11 | CRISPR Therapeutics AG | CRSP | High Katherine A Director | 30,000 | $43.52 | 30,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-13 5:07 pm | N/A 2029-06-11 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 15,000 | $43.52 | 15,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-13 5:05 pm | N/A 2029-06-11 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $43.52 | 15,000 (Indirect) | View |
| 2019-06-11 Option Award | 2019-06-13 5:05 pm | N/A 2029-06-11 | CRISPR Therapeutics AG | CRSP | Greene John Director | 30,000 | $43.52 | 30,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-13 5:04 pm | N/A 2029-06-11 | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 15,000 | $43.52 | 15,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-13 5:04 pm | N/A 2029-06-11 | CRISPR Therapeutics AG | CRSP | George Simeon Director | 15,000 | $43.52 | 15,000 (Direct) | View |
| 2019-06-01 Tax Withholding | 2019-06-04 4:25 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 741 | $35.57 | 165,801 (Direct) | View |
| 2019-04-29 Exercise | 2019-05-01 4:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $1.81 | 223,058 (Direct) | View |
| 2019-04-29 Exercise | 2019-05-01 4:05 pm | N/A 2025-09-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 20,000 | $1.81 | 223,058 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 4:17 pm | N/A 2029-03-05 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 45,000 | $40.87 | 45,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 4:14 pm | N/A 2029-03-05 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN CFO | 75,000 | $40.87 | 75,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 4:14 pm | N/A 2029-03-05 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 65,000 | $40.87 | 65,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 4:12 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Ho Tony W See Remarks | 10,000 | $40.87 | 75,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 4:12 pm | N/A 2029-03-05 | CRISPR Therapeutics AG | CRSP | Ho Tony W See Remarks | 75,000 | $40.87 | 75,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 4:11 pm | N/A 2029-03-05 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 250,000 | $40.87 | 250,000 (Direct) | View |
| 2019-03-01 Tax Withholding | 2019-03-05 5:57 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth CEO | 748 | $39.97 | 166,542 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 4:32 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $29.87 | 20,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 4:32 pm | N/A 2029-01-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $29.87 | 20,000 (Direct) | View |